March, 2020 | PharmaShots

Lilly Signs a Worldwide License and Research Agreement with Sitryx to Develop New Immunometabolic Therapies

March 31, 2020March 31, 2020Tuba Khan

Shots: Sitryx to receive $50M upfront, $10M equity investment, ~820M as development & commercial milestones and royalties on sales of therapies. Lilly to [Read More...]

AstraZeneca’s Lokelma Receives CHMP’s Recommendation for Approval for Patients with Hyperkalemia on Stable Hemodialysis

March 31, 2020March 31, 2020Tuba Khan

Shots: The EMA’s CHMP has adopted a positive opinion on a dosing and administration label update for AstraZeneca’s Lokelma to include patients with [Read More...]

The US FDA Authorizes the Emergency Use of Antimalarial Drugs to Combat COVID-19

March 31, 2020March 31, 2020Tuba Khan

Shots: The US FDA has issued the EUA to the hydroxychloroquine and chloroquine products donated to the Strategic National Stockpile (SNS) to be [Read More...]

Bayer’s Nubeqa (darolutamide) Receives the EC’s Approval for Men with Non-Metastatic Castration-Resistant Prostate Cancer

March 31, 2020March 31, 2020Tuba Khan

Shots: The EC’s approval is based on P-III ARAMIS study assessing Nubeqa (600mg, bid) + ADT vs PBO + ADT 1,509 patients in [Read More...]

Abbott Receives FDA’s Emergency Use Authorization for its Point-Of-Care Test to Detect Novel COVID-19 in Five Minutes

March 31, 2020March 31, 2020Tuba Khan

Shots: Abbott has received the US FDA’s EUA for its molecular point-of-care test to detect novel COVID-19 and runs on its ID NOW [Read More...]

Additionally, J&J to establish new vaccine manufacturing capabilities in the US and production capacity outside the US to begin production of the vaccine, will enable to supply ~1B doses of vaccine globally

Johnson & Johnson and BARDA to Fund ~$1B in Research and Development of Novel COVID-19 Vaccines

March 31, 2020March 31, 2020Tuba Khan

Shots: The collaboration follows the existing partnership b/w J&J and BARDA while the company expects to initiate the clinical studies of selected vaccine [Read More...]

Insights+ Exclusive: COVID-19 Healthcare News Updates

March 31, 2020April 24, 2020Tuba Khan

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop it. The COVID-19 [Read More...]

BMS Reports Results of Triple Regimen in P-III ELOQUENT-1 Study for Patients with Newly Diagnosed Untreated Multiple Myeloma

BMS’s Zeposia (ozanimod) Receives the CHMP’s Positive Opinion to Treat Adults with Relapsing-Remitting Multiple Sclerosis with Active Disease

March 30, 2020March 31, 2020Tuba Khan

Shots: The approval is based on P-III SUNBEAM & RADIANCE Part B studies assessing Zeposia (0.92 mg and 0.46 mg, equivalent to 1 [Read More...]

Eli Lilly’s Taltz (ixekizumab) Receives the US FDA’s Approval for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis

March 30, 2020March 30, 2020Tuba Khan

Shots: The approval is based on P-III study assessing Taltz (20mg for <25kg/40mg for 25-50kg/80 mg for >50 kg @12wks., with 40/80/160mg starting [Read More...]